FibroGen (NASDAQ:FGEN) Research Coverage Started at StockNews.com
StockNews.com began coverage on shares of FibroGen (NASDAQ:FGEN – Free Report) in a research report sent to investors on Thursday. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, William Blair restated a market perform rating on shares of FibroGen in a research note on Monday, June 3rd. Get Our Latest Analysis […]
22 Sep 07:49 · The Markets Daily